Event Details

This document is a page from a Cowen 'Collaborative Insights' market report dated February 25, 2019, bearing the Bates stamp HOUSE_OVERSIGHT_024893. It details regulatory crackdowns and guidance regarding CBD (cannabidiol) products in Maine, New York, and North Carolina, specifically noting that these states are aligning with FDA guidance to prohibit CBD in food additives while creating specific frameworks for supplements or topicals. While part of the House Oversight production (likely related to financial records), the text itself discusses cannabis industry regulations and does not mention Jeffrey Epstein or his associates.